A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2011
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101693718B Ester derivative containing thienopyridine and preparation method and application thereof
10/19/2011	CN101573300B Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution
10/19/2011	CN101327200B Glycerol fruit sugar injection and preparation method thereof
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/19/2011	CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/19/2011	CN101152147B Ligustrazine compound emulsion and method for preparing the same
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2403218C Embolic compositions
10/18/2011	CA2252986C Process for preparing functional recombinant tissue factor
10/13/2011	WO2011127472A1 Compositions and methods for providing hematopoietic function
10/13/2011	WO2011127470A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	WO2011127300A1 Crystalline forms of prasugrel salts
10/13/2011	WO2011127181A2 System and method for the release of nitric oxide using nanoscale media
10/13/2011	WO2011127176A2 Methods for treating or screening for compounds for the treatment of sepsis
10/13/2011	WO2011126965A1 A novel botanical formulation for treating sickle cell disease
10/13/2011	WO2011126903A2 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	WO2011125916A1 Composition for amelioration of hypoalbuminemia
10/13/2011	WO2011124998A1 Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
10/13/2011	WO2011124430A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/13/2011	WO2011124124A1 Prasugrel hydrochloride acetic acid solvate and its crystalline, preparation method thereof
10/13/2011	WO2011060242A3 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
10/13/2011	WO2011047040A3 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells
10/13/2011	US20110251593 In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
10/13/2011	US20110251281 Composite Material Comprising High-Molecular-Weight Matrix and Low-Molecular-Weight Organic Compound and Process For Producing Same
10/13/2011	US20110251176 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	US20110251160 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/13/2011	US20110251149 Methods and low dose regimens for treating red blood cell disorders
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251127 Inactivation of infectious agents in plasma proteins by extreme pressure
10/13/2011	US20110251123 Oral pharmaceutical composition of desmopressin
10/13/2011	US20110250296 Reverse vitamin k effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets
10/13/2011	US20110250291 Use of arsenic for cancer therapy protection
10/13/2011	US20110250287 One step removal of selected molecules from body fluid and tissue
10/13/2011	US20110250284 Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
10/13/2011	US20110250255 Drug coated stent with endosome-disrupting conjugate
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250207 Anti-fxi antibodies and methods of use
10/13/2011	US20110250197 Pharmaceutical combination
10/13/2011	US20110250181 Human lysosomal proteins from plant cell culture
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	CA2829790A1 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	CA2795938A1 Compositions and methods for providing hematopoietic function
10/13/2011	CA2795627A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	CA2794428A1 Substituted 3,5-diphenyl-isoxazoline derivatives as insecticides and acaricides
10/13/2011	CA2793951A1 Composition for amelioration of hypoalbuminemia
10/13/2011	CA2788762A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/12/2011	EP2374878A2 Novel adamts-13 mutant
10/12/2011	EP2374805A1 Crystals of hydrochloride of pyridazin-3(2h)-one compound and process for production of same
10/12/2011	EP2374798A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374797A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374456A1 Activated blood coagulation factor x (fxa) inhibitor
10/12/2011	EP2373691A2 Anti-fxi antibodies and methods of use
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216310A Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
10/12/2011	CN102215869A Methods and compositions for regulating iron homeostasis by modulation bmp-6
10/12/2011	CN102212512A Pegylated staphylokinase mutant, and preparation method and application thereof
10/12/2011	CN102212148A Antithrombotic medicament for intravenous injection and preparation method and application thereof
10/12/2011	CN102212125A Recombinant lamprey lysin as well as preparation method and application thereof in preparing antithrombotic medicament
10/12/2011	CN102212074A Cefonicid sodium hydrate and preparation method and application thereof
10/12/2011	CN102212071A Prasugrel hydrochloride acetic acid solvate as well as crystal and preparation method thereof
10/12/2011	CN102212069A Cycloalkane derivative, preparation method thereof and application thereof in medicaments for cardiovascular and cerebrovascular diseases
10/12/2011	CN102212068A Thiofuran derivative, preparation method thereof and application thereof in medicaments
10/12/2011	CN102212001A Compound salvianolic acid F methyl ester and preparation method thereof
10/12/2011	CN102210872A Polyethylene glycol modified peptide pharmaceutical formulation and preparation method thereof
10/12/2011	CN102210818A Chinese medicine for treating gastrorrhagia
10/12/2011	CN102210792A Traditional Chinese medicine for preventing and treating deep venous thrombosis
10/12/2011	CN102210783A Composition preparation of donkey-hide glue, and preparation method thereof
10/12/2011	CN102210762A Application of Chinese medicine composition in preparation of medicine for preventing nonvalvular atrial fibrillation thrombo-embolism
10/12/2011	CN102210745A Medicinal liquor and preparation method thereof
10/12/2011	CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof
10/12/2011	CN102210731A Soft capsule containing notoginseng adventitious root extract
10/12/2011	CN102210730A Medicinal composition containing pseudo-ginseng adventitious root extract
10/12/2011	CN102210726A Method for combined extraction of mallow flavones and mallow saponins in seashore mallow and application
10/12/2011	CN102210718A Method for preparing composite-probiotic-fermented Chinese herbal medicine
10/12/2011	CN102210706A Polypeptide donkey-hide gelatine dextran freeze-drying preparation and preparing process thereof
10/12/2011	CN102210705A Production process of polypeptide donkey-hide gelatin substitutive blood plasma
10/12/2011	CN102210704A Process for removing pyrogen from polypeptide donkey-hide gelatin dextran
10/12/2011	CN102210703A Dextran of polypeptide donkey-hide gelatin
10/12/2011	CN102210702A Calf spleen extract for treating tumors
10/12/2011	CN102210693A Method for preparing aspirin and dipyridamole multilayer tablets
10/12/2011	CN102210669A Application of salvia extract in treating septicemia
10/12/2011	CN102210667A Application of phenolic acid compounds in preparation of bleeding stopping and stasis eliminating medicaments
10/12/2011	CN102210666A Medical use of salvianolic acid A
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210656A Medicinal composition containing carbazochrome sodium sulfonate compound and preparation method thereof
10/12/2011	CN101428050B Active composition for treating thrombus, cardio-cerebrovascular system diseases
10/12/2011	CN101389613B Macrocyclic factor viia inhibitors useful as anticoagulants
10/12/2011	CN101347593B Decoction medicament for treating haematemesis induced by chronic gastritis
10/11/2011	US8034763 Platelet aggregation inhibitor composition
10/11/2011	US8034615 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases

1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 671